notec AMD Ltd. is pleased to announce it has been recently added as an approved supplier to the UK’s NHS Supply Chain and NHS Shared Business Services (NHS SBS). Known for its innovative technology in advanced medical devices, Inotec is the maker of NATROX® Oxygen Wound Therapy. Its addition marks the first time continuous topical oxygen therapy (cTOT) has been listed. This new category means NHS staff, publicly funded organisations, hospitals, and wound care clinics can easily prescribe this highly effective therapy.
What is NATROX® Oxygen Wound Therapy
NATROX® Therapy is designed to heal chronic, hard-to-heal wounds. The innovative, simple device delivers pure humidified oxygen 24/7 directly to a wound to stimulate and improve healing. Battery-powered, portable, and completely silent, the active therapy is easy to maintain until a wound heals. It can be used during any phase of wound healing, works with any standard secondary dressing, and can even be used by patients remotely at home.
“We’re excited to become an approved NHS Supply Chain and NHS SBS supplier,” said Craig Kennedy, Inotec CEO. “But what’s even more exciting is the opportunity to transform the quality of life for so many patients who’ve potentially put their lives on hold just waiting to heal.”
The Burden of Chronic Wounds
Commonly understood as unhealed for at least three months1, chronic wounds pose a significant problem to both patients’ quality of life and healthcare systems worldwide2. Prevalent and costly, wound management accounts for healthcare expenditures of £8.3bn in the UK annually, of which 67% is spent managing unhealed, chronic wounds3.
“Knowing how high the stakes are and how many patients we can help is why I got involved,” said Dr. Adrian Parton MBE, Chairman of the Board at Inotec. The Cambridge-based firm focuses on groundbreaking innovation in advanced wound care technology. From award-winning products to its award-winning team, the young company has quickly captured the attention of many as a market leader in chronic wound healing.
Creating a New Category
Adding NATROX® Oxygen Wound Therapy to the NHS supplier frameworks marks the first time cTOT will be listed as a category. A mounting body of evidence demonstrates that topical oxygen therapy can improve both patient outcomes and quality of life5, 6, 7, 8.
“This move further validates NATROX® Therapy as an effective, needed treatment for patients across the UK suffering from hard-to-heal wounds,” said Parton. Making NATROX® Oxygen Wound Therapy widely available means improved wound healing, a higher likelihood of patient compliance, and a better quality of life.
“We believe NATROX® Therapy is poised to become the new standard in wound care,” said Parton.
Who are NHS Supply Chain and NHS SBS
NHS Supply Chain manages the sourcing, delivery and supply of healthcare products, services, and food for NHS trusts and healthcare organisations across England and Wales. NHS SBS delivers corporate services to the NHS, providing finance & accounting, procurement, and workforce services to more than half the NHS in England.
The goal of these providers is to help the NHS save money and enhance quality to allow the NHS to improve health, innovate to save lives, and deliver better outcomes with care and compassion.
“We work in partnership with suppliers focused on innovation whose products encourage good patient outcomes and support clinicians’ decision-making processes in both clinical and home care settings,” said Sue Mason, Senior Clinical Nurse Advisor at NHS SBS.
An estimated 85% of wound care costs9 relate to nursing and home visits rather than the wound dressing itself. With this in mind, the NHS SBS developed its Advanced Wound Care and Lymphoedema Products and Services Framework, under which NATROX® Oxygen Wound Therapyis listed, to help NHS nurses reduce time managing wounds.
“We help ensure clinicians can procure all their wound care needs via one route, enabling them to direct their time and resources back to patient care,” said Mason.
[ Tratto da: www.natroxwoundcare.com ]